Shield Therapeutics plc (STX.L)

GBp 2.75

(1.85%)

Revenue Summary of Shield Therapeutics plc

  • Shield Therapeutics plc's latest annual revenue in 2023 was 13.08 Million GBP , up 135.65% from previous year.
  • Shield Therapeutics plc's latest quarterly revenue in 2024 Q2 was 9.59 Million GBP , down 0.0% from previous quarter.
  • Shield Therapeutics plc reported a annual revenue of 4.46 Million GBP in annual revenue 2022, up 194.08% from previous year.
  • Shield Therapeutics plc reported a annual revenue of 1.51 Million GBP in annual revenue 2021, down -85.38% from previous year.
  • Shield Therapeutics plc reported a quarterly revenue of 6.98 Million GBP for 2023 Q4, down 0.0% from previous quarter.
  • Shield Therapeutics plc reported a quarterly revenue of 3.51 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Shield Therapeutics plc (2023 - 2014)

Historical Annual Revenue of Shield Therapeutics plc (2023 - 2014)

Year Revenue Revenue Growth
2023 13.08 Million GBP 135.65%
2022 4.46 Million GBP 194.08%
2021 1.51 Million GBP -85.38%
2020 10.38 Million GBP 1344.65%
2019 719 Thousand GBP -93.95%
2018 11.88 Million GBP 1765.15%
2017 637 Thousand GBP 109.54%
2016 304 Thousand GBP 0.0%
2015 - GBP 0.0%
2014 - GBP 0.0%

Peer Revenue Comparison of Shield Therapeutics plc

Name Revenue Revenue Difference